Barclays PLC Royalty Pharma PLC Transaction History
Barclays PLC
- $854 Billion
- Q3 2025
A detailed history of Barclays PLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Barclays PLC holds 552,559 shares of RPRX stock, worth $21.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
552,559
Previous 339,362
62.82%
Holding current value
$21.6 Million
Previous $12.2 Million
59.43%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding RPRX
# of Institutions
536Shares Held
303MCall Options Held
1.34MPut Options Held
252K-
Morgan Stanley New York, NY44.2MShares$1.73 Billion0.1% of portfolio
-
Capital International Investors Los Angeles, CA27.2MShares$1.07 Billion0.16% of portfolio
-
Black Rock Inc. New York, NY23MShares$901 Million0.01% of portfolio
-
Baillie Gifford & CO17.4MShares$680 Million0.48% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$478 Million0.45% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $17.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...